Host: Denise M. Dupras, M.D., Ph.D.

Guest: Jewel J. Samadder, M.D., Gastroenterologist and Professor, Mayo Clinic

In this episode of Mayo Clinic Talks, Dr. Denise Dupras interviews Dr. Jewel Samadder about colon cancer, with a focus on how genetics and family history influence cancer risk and screening strategies. Dr. Samadder emphasizes empowering primary care providers to identify patients who may benefit from genetic evaluation and early colonoscopy. He encourages clinicians to take thorough family histories and use them to guide screening strategies, helping catch cancer early — or prevent it entirely.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts

Host: Danielle O’Laughlin, PA-C, MS and Jenna Wygant, APRN, CNP, DNP

Guest: Nicole Callahan, APRN, CNP, MS

In this episode, along with guest Nicole Callahan, APRN, CNP, MS, we explore reproductive health challenges. Starting with the different types of miscarriage—identifying their unique anatomic changes, symptoms, and outcomes. We will cover the basics of both female and male infertility, including when it’s the ideal time to refer patients for specialized care. Finally, we explore ectopic pregnancy, discussing common locations, risk factors, clinical presentation, diagnostic approach, and treatment options.

By the end of this podcasts, listeners will be able to:

1. Identify the differences in anatomic changes, symptoms, and outcomes in the types of miscarriage.
2. Understand the basics in female and male infertility and when to refer for more advanced care.
3. Describe an ectopic pregnancy in regard to most common location, risk factors, signs and symptoms, diagnosis, and treatment options.

Learn more about this series: Mayo Clinic Talks: Obstetric and Gynecologic Health | Mayo Clinic School of Continuous Professional Development

Connect and listen with Mayo Clinic Podcasts | Mayo Clinic School of Continuous Professional Development

Host: Denise M. Dupras, M.D., Ph.D.

Guest: Saad J. Kenderian, M.B., Ch.B.

Dr. Saad Kenderian discusses the use of CAR-T cell therapy, a groundbreaking treatment that genetically modifies a patient's T-cells to target and destroy cancer cells, particularly in blood cancers like leukemia and lymphoma. He highlights the importance of identifying eligible patients, monitoring treatment response, and applying genomics to guide the future of personalized cancer immunotherapy.

Connect with us and learn more here: https://ce.mayo.edu/online-education/content/mayo-clinic-podcasts